drug · oligonucleotide
patient view →nedosiran sodium
Marketedupdated 2mo agoby Novo Nordisk AS🔗 ChEMBL
Approvedcommunity read0 votes
Oligonucleotide drug with a maximum clinical stage of Approval, with an approval for primary hyperoxaluria.
targets
L-lactate dehydrogenase A chain mRNA
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that